Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Falciparum Malaria”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01594931
What this trial is testing

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Medicines for Malaria Venture 477
Testing effectiveness (Phase 2)Study completedNCT05689047
What this trial is testing

Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)

Who this might be right for
Acute Malaria
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 38
Testing effectiveness (Phase 2)Study completedNCT00459615
What this trial is testing

Phase II Dose Ranging Study of Artesunate

Who this might be right for
Falciparum MalariaUncomplicated Malaria
U.S. Army Office of the Surgeon General 120
Testing effectiveness (Phase 2)Study completedNCT01524341
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics of KAE609 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria
Novartis Pharmaceuticals 27
Testing effectiveness (Phase 2)Ended earlyNCT02880241
What this trial is testing

MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria

Who this might be right for
Malaria
Medicines for Malaria Venture 8
Post-approval studies (Phase 4)Study completedNCT00444106
What this trial is testing

Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function

Who this might be right for
MalariaFalciparum
Novartis 265
Testing effectiveness (Phase 2)Study completedNCT01753323
What this trial is testing

Efficacy, Safety, Tolerability and Pharmacokinetics of KAF156 in Adult Patients With Acute, Uncomplicated Plasmodium Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria
Novartis Pharmaceuticals 43
Not applicableStudy completedNCT01163877
What this trial is testing

Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma

Who this might be right for
Malaria, FalciparumHookworm InfectionsSchistosoma Haematobium
Swiss Federal Institute of Technology 43
Testing effectiveness (Phase 2)Study completedNCT00243737
What this trial is testing

Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria

Who this might be right for
Malaria
Albert Schweitzer Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01213966
What this trial is testing

Efficacy, Tolerability, PK of OZ439 in Adults With Acute, Uncomplicated P.Falciparum or Vivax Malaria Mono-infection

Who this might be right for
Malaria, FalciparumMalaria, Vivax
Medicines for Malaria Venture 82
Large-scale testing (Phase 3)Study completedNCT00371735
What this trial is testing

Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 900
Testing effectiveness (Phase 2)Study completedNCT01836458
What this trial is testing

Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection

Who this might be right for
Malaria
Novartis Pharmaceuticals 25
Testing effectiveness (Phase 2)UnknownNCT02198807
What this trial is testing

Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria

Who this might be right for
Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
Jomaa Pharma GmbH 100
Testing effectiveness (Phase 2)Study completedNCT01860989
What this trial is testing

Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection

Who this might be right for
Cure Rate
Novartis Pharmaceuticals 11
Testing effectiveness (Phase 2)Study completedNCT00299208
What this trial is testing

Azithromycin Combination Therapy for Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 120
Large-scale testing (Phase 3)Study completedNCT00709969
What this trial is testing

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
Novartis 310
Not applicableStudy completedNCT00157859
What this trial is testing

To Evaluate Current Efficacy of Antimalarials Used in Timika, Papua, Indonesia

Who this might be right for
Falciparum MalariaVivax Malaria
Menzies School of Health Research 150
Large-scale testing (Phase 3)Study completedNCT05192265
What this trial is testing

Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine

Who this might be right for
Malaria FeverPlasmodium Falciparum MalariaUncomplicated Malaria
University of Ibadan 172
Early research (Phase 1)Study completedNCT02612545
What this trial is testing

Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia

Who this might be right for
Acute Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 216
Large-scale testing (Phase 3)Study completedNCT00386763
What this trial is testing

Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria.

Who this might be right for
MalariaFalciparum
Novartis 890
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation